ROBERT GARDNER: Open Payments
NPI 1649365917 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,966 in 166 payments from 41 companies in 2025. Trend: 2023 $7,022 · 2024 $6,859 · 2025 $21,966
Speaker / faculty: $16,931Food & beverage: $3,652Travel & lodging: $858Consulting: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $17,480 |
| Janssen Pharmaceuticals, Inc | 11 | $1,016 |
| Eisai Inc. | 6 | $264 |
| Novartis Pharmaceuticals Corporation | 8 | $252 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $225 |
| Teva Pharmaceuticals USA, Inc. | 12 | $222 |
| JAZZ PHARMACEUTICALS INC. | 4 | $214 |
| Janssen Biotech, Inc. | 5 | $207 |
| TG Therapeutics, Inc. | 6 | $190 |
| Amneal Pharmaceuticals LLC | 5 | $183 |
Products named: QULIPTA, SPRAVATO, Leqembi, KESIMPTA, LUMRYZ, AUSTEDO XR, XYWAV, BRIUMVI.
Industry payments across MO — which companies pay providers there.
